I don't really have an answer for that. If they're an OTC company, they still have to file a corporate action request with FINRA. They'll also have to get a ticker for the spinoff from FINRA, and file a 211 for it.
I'm not 100% sure, but I think they'll find it doesn't work the way they think it does. But have you read the S-1? Maybe it's clarified there.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.